Shareholders Equity: The sum of preferred and common equity items.
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) had Shareholders Equity of $2.55M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.70M |
|
-- |
|
-- |
|
$3.79M |
|
$-3.79M |
|
$0.10M |
|
$-3.70M |
|
$-3.70M |
|
$-3.70M |
|
$-3.70M |
|
$-3.70M |
|
$-3.70M |
|
$-3.79M |
|
$-3.77M |
|
0.59M |
|
0.59M |
|
$-6.28 |
|
$-6.28 |
|
| Balance Sheet Financials | |
$8.48M |
|
-- |
|
$0.43M |
|
$8.91M |
|
$4.34M |
|
-- |
|
$2.02M |
|
$6.36M |
|
$2.55M |
|
$2.12M |
|
|
Shareholders Equity |
$2.55M |
0.59M |
|
| Cash Flow Statement Financials | |
$-6.28M |
|
$4.45M |
|
$-0.13M |
|
$3.62M |
|
$1.67M |
|
$-1.95M |
|
$0.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-144.86% |
|
-174.50% |
|
-41.47% |
|
-144.86% |
|
$4.34 |
|
$-3.11 |
|
$-10.68 |
|